Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABI-007 in Metastatic Melanoma
NCT00081042Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Feb 2004
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in melanoma, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Feb 2004; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00081042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081042.